Devices & Diagnostics

Boston Scientific’s Genesys HTA treatment gets early FDA approval

Boston Scientific Corp. (NYSE: BSX) won Food & Drug Administration approval for its Genesys HTA menorrhagia treatment. The Natick, Mass.-based medical devices giant said the device treats excessive menstrual bleeding by ablating the endometrial lining of the uterus. It’s an upgrade of Boston Scientific’s HTA system featuring a new console, easier set-up, a graphic user […]

Boston Scientific Corp. (NYSE: BSX) won Food & Drug Administration approval for its Genesys HTA menorrhagia treatment.

The Natick, Mass.-based medical devices giant said the device treats excessive menstrual bleeding by ablating the endometrial lining of the uterus. It’s an upgrade of Boston Scientific’s HTA system featuring a new console, easier set-up, a graphic user interface and “several technology upgrades designed to improve operating performance,” according to a press release.

The Genesys enhancements won CE Mark approval in the European Union in January, according to the release.

Its competition includes a local entry, the NovaSure ablation treatment made by Bedford, Mass.-based Hologic Inc. (NSDQ:HOLX). Hologic touted the 1-millionth NovaSure procedure last summer.

The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.

Sponsored Post

Physician Targeting Using Real-time Data: How PurpleLab’s Alerts Can Help

By leveraging real-time data that offers unprecedented insights into physician behavior and patient outcomes, companies can gain a competitive advantage with prescribers. PurpleLab®, a healthcare analytics platform with one of the largest medical and pharmaceutical claims databases in the United States, recently announced the launch of Alerts which translates complex information into actionable insights, empowering companies to identify the right physicians to target, determine the most effective marketing strategies and ultimately improve patient care.

This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.